Journey Medical Financials - Benzinga

Journey Medical Corp

DERMNASDAQ

Trade with Public

Trade with Public

$7.53

-0.015-0.2%

At close: Aug 27, 5:00 PM EST

$7.53

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Journey Medical Financials

Journey Medical (DERM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Journey Medical Q2 EPS $(0.01) Beats $(0.02) Estimate, Sales $17.839M Miss $18.366M Estimate

Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 93.75 percent increase over losses of $(0.16) per share from the

Benzinga Newsdesk

PRO
Journey Medical Q1 EPS $(0.08), Inline, Sales $15.961M Beat $15.948M Estimate

Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 55.56 percent increase over losses of $(0.18) per share from the same period last year.

Benzinga Newsdesk

Earnings Scheduled For May 13, 2026

Benzinga Insights

PRO
Journey Medical Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $16.079M Miss $18.863M Estimate

Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 31.03 percent. This is a 150 percent decrease over earnings of $0.08 per share from the

Benzinga Newsdesk

Earnings Scheduled For March 25, 2026

Benzinga Insights

PRO
Journey Medical Q3 EPS $(0.09) Misses $(0.04) Estimate, Sales $17.631M Miss $18.854M Estimate

Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 143.24 percent. This is a 25 percent increase over losses of $(0.12) per share from

Benzinga Newsdesk